Cite
HARVARD Citation
Forton, D. et al. (n.d.). OC-010 Final efficacy and safety in hcv genotype 1-infected patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir ± ribavirin: topaz-i results from the united kingdom and ireland. Gut. pp. A5-A6. [Online].